Acute myelitis as presenting symptom of HIV-HTLV-1 co-infection

J Neurovirol. 2016 Dec;22(6):861-865. doi: 10.1007/s13365-016-0455-2. Epub 2016 May 31.

Abstract

A 21-year-old woman presented with acute-onset spastic paraparesis. The MRI spinal scan revealed a contrast-enhanced T2 hyperintensity between C5-T2. The most common neurotropic pathogens were excluded by first level tests. Under suspicion of an acute immune-mediated myelitis, a corticosteroid therapy was administered. However, a seropositivity for both human immunodeficiency virus (HIV) type 1 and human T-lymphotropic virus (HTLV) subsequently emerged. An antiretroviral therapy was started while steroids discontinued. Patient's clinical conditions remained unchanged. HIV-HTLV-1 co-infection should be included in the differential diagnosis of any acute myelitis, even in patients with a preserved immune status and no risk factors.

Keywords: HIV; HTLV; Myelitis.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Viral / blood
  • Antibodies, Viral / cerebrospinal fluid
  • Antiviral Agents / therapeutic use
  • Coinfection
  • Diagnosis, Differential
  • Female
  • HIV / pathogenicity*
  • HIV Infections / diagnosis*
  • HIV Infections / drug therapy
  • HIV Infections / pathology
  • HIV Infections / virology
  • HTLV-I Infections / diagnosis*
  • HTLV-I Infections / drug therapy
  • HTLV-I Infections / pathology
  • HTLV-I Infections / virology
  • Human T-lymphotropic virus 1 / pathogenicity*
  • Humans
  • Magnetic Resonance Imaging
  • Paraparesis, Tropical Spastic / diagnosis*
  • Paraparesis, Tropical Spastic / drug therapy
  • Paraparesis, Tropical Spastic / pathology
  • Paraparesis, Tropical Spastic / virology
  • Young Adult

Substances

  • Antibodies, Viral
  • Antiviral Agents